Cell and gene therapies may well be some of the most important recent advancements in modern medicine. The way they work, however, is very complex and completely different from any pill that simply addresses symptoms. So, who are the pioneers in this field and what dares them to ask, “what if”?  In this episode of the Biotech Innovators podcast, learn from Ainslie Little, senior vice president of corporate strategy at BlueRock Therapeutics, and how her company’s cell & gene platform is breaking new ground in this important space.This content is offered for informational purposes only. The opinions stated in this podcast are that of the speaker and do not constitute or imply an endorsement by Thermo Fisher Scientific.